News

A recent study has found that a skin ointment containing cannabigerol (CBG) and cannabidiol (CBD) may help ease the symptoms of atopic dermatitis, c ...
Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac's decision to widen access ...
Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac’s ...
It’s one thing to experience difficulty with locking moisture in your skin from time to time, but if the occasional itchiness and dryness linger, causing your skin to feel scaly, patchy, or like ...
Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission.
An expert discusses the existing gaps in atopic dermatitis (AD) management, promising areas of research to address unmet needs, and key takeaways from the discussion for the managed care audience ...
A prospective registry study found a greater risk for infections associated with JAK inhibitors in adolescents and adults with moderate to severe atopic dermatitis compared with biologics.
Researchers have developed a scoring tool that predicts whether a child with a suspected food allergy really has one. The ...
Some topical cannabinoid therapies could be a safe and effective treatment for patients with atopic dermatitis (AD) says a ...
In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.
In this video, Raj Chovatiya, MD, PhD, discussed continued updates in the use of topical ruxolitinib in pediatric patients with atopic dermatitis.
In a recent Fox News interview, Kennedy said "there's a lot of studies out there that show that if you actually do get the wild infection, you're protected later. It boosts your immune system later in ...